Aridis PharmaceuticalsARDS
13F holders, Q1 2026 (March 31)1holders
1new positions
0sold out
$0.00avg. 13F price*
At the end of Q1 2026, 1 institutions reported holding Aridis Pharmaceuticals Inc. (ARDS) in their 13F filings, unchanged from Q3 2025. 1 opened new positions and 0 sold out. The largest holder was Strengthening Families & Communities, LLC ($1).
- Company
- Aridis Pharmaceuticals Inc.
- CUSIP
- 040334104
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q3 2025 → Q1 2026
| Institutions | Total Value | |
|---|---|---|
| New Positions | 1 | $1 |
| Exits | 0 | $0 |
All 13F filers, Q3 2025 → Q1 2026: 3,000 shares bought, net +3,000 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 1 holders
| Strengthening Families & Communities, LLC | 0.00% | New | 3,000 | $1 |
"% of holder's portfolio" is ARDS's weight in each manager's 13F, not the share of Aridis Pharmaceuticals Inc. the manager owns.